Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Input: Consider Input: Paragraph: Voters in both Western states approved ballot initiatives in 2012 allowing personal possession and use of marijuana by anyone aged 21 and or older for purposes of just getting high, though public consumption of pot remains illegal. In January the world’s first state-licensed retail marijuana outlets opened for business in Colorado, and stores in Washington are set to follow suit later this year. Both states are among 20 that have already removed criminal sanctions for medical use of marijuana. The federal government still classifies marijuana as an illegal narcotic, but the Obama administration has given states new leeway to experiment with legalized cannabis. In Denver’s Civic Center Park near the state capitol, revelers on Sunday gathered to hear music and listened to speakers during a weekend event that organizers billed as the “world’s largest 4/20 rally.”  The date of April 20, or 4/20, corresponds to the numerical code widely recognized within the cannabis subculture as a symbol for all things marijuana. Police officers standing by on the fringes of the Denver festival issued 63 citations on Sunday, most for smoking pot in public - a ticket that carries a fine of $150. About half as many were cited on Saturday, police said. At least eight individuals were taken to a detoxification facility for treatment during the two days, police said. Denver police spokesman Sonny Jackson said officers have refrained from wading into the crowd to arrest violators, but instead were citing people who openly defied the public consumption ban. “Those ticketed were blatantly in violation of state law and city ordinances,” Jackson said. Organizers of the rally and city officials beefed up security at the event after three people were wounded by gunfire at last year’s rally. Separately, the Cannabis Cup, a trade show sponsored by High Times magazine, drew sold-out crowds over the weekend at a Denver convention venue. The two-day event featured marijuana sampling and workshops, such as how to open a pot shop, cultivation tips, and how to talk to children about weed, according to the event’s website. Rachel O’Bryan, spokeswoman for Smart Colorado, an organization that advocates for stricter enforcement of marijuana laws, said the cannabis industry needs to do more to police its own. “People are flouting the law by openly consuming,” she said. “We’re concerned about the message that sends to our kids.”  In Seattle, several hundred people who paid $15 a head crowded the cavernous interior of a former brewery where Rainier Beer was made for decades to attend a 4/20 gathering organized by sponsors of the city’s annual Hempfest rally. Reggae music played over loudspeakers and the air inside was thick with the sweet, skunky odor of cannabis. But no police were visible at the event, which organizers deliberately held on private space leased from the brewery owners in an industrial section of the city south of downtown. The gathering featured a workshop on how to roll a joint with an entire ounce (28 grams) of marijuana - the legal limit for personal possession in the state - as well as vendors selling pipes and other paraphernalia, and a blind-toke test in which participants tried to distinguish between different strains of pot by sampling them. Attendees ranged from middle-aged baby boomers to a younger crowd from the so-called millennial generation. A cheer from the crowd went up at precisely 4:20 p.m. local time, as many attendees milling about outside lit joints and pipes simultaneously, sending puffs of smoke into the air followed by raucous fits of coughing. One woman in the crowd accepted a joint handed her from a bearded bystander. “You look just like Jesus,” she exclaimed in an apparent reference to the event coinciding with Easter Sunday. “How does it feel to be risen?”  Doug Medina, 54, said he traveled hundreds of miles with his wife and daughter from Billings, Montana, to Seattle for the 4/20 weekend celebrations there. “It feels a little more open than it did five or 10 years ago,” he said while smoking a joint outside the brewery. Claim: Marijuana fans pack 4/20 events in Colorado, Washington state.

Output: Thousands of marijuana enthusiasts gathered in Colorado and Washington state over the weekend for an annual celebration of cannabis culture with rallies, concerts and trade shows in the first two U.S. states to legalize recreational marijuana.


Input: Consider Input: Paragraph: Israel-based BrainStorm said on Monday a case report is being published in the February issue of “Muscle & Nerve” by the principal investigator and his colleagues at Hadassah Hospital in Jerusalem and a professor from the Mayo Clinic in Minnesota. The report is already available online. A 75 year-old-man diagnosed with both MG and amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease, was treated with BrainStorm’s NurOwn cells. Both are neurodegenerative diseases. One month after receiving injections of the cells, the patient and his family reported significant improvement in cognition, speech, and muscle power. After six months, due to progression of weakness and deterioration in cognition, a repeat injection of NurOwn was performed. Again, improvements in the ALS functional rating scale were observed, the report said, adding that treatment with NurOwn appeared safe and well tolerated. “The results suggest that repeated therapy may maintain and enhance the clinical benefits of NurOwn cell therapy in neurological diseases,” it said. Chaim Lebovits, president of BrainStorm, said the report in “Muscle & Nerve” was very promising. “This publication is an important milestone for BrainStorm as this is the first human data on NurOwn to be published in a prestigious scientific journal,” he said. He said the company expects to finalize its Phase IIa clinical trial in the first half of 2014. According to the ALS Association, 5,600 people in the United States are diagnosed each year with the disease, which has severely disabled British physicist Stephen Hawking. Claim: BrainStorm says stem cells helped patient with ALS and MG.

Output: A patient suffering from both ALS and myasthenia gravis (MG) showed significant improvement in cognitive and motor function following treatment with BrainStorm Cell Therapeutics adult stem cells, according to a published case report.


Input: Consider Input: Paragraph: The accord announced on Thursday by the U.S. Department of Justice resolves allegations that CareFusion violated the federal False Claims Act by paying $11.6 million to a doctor to promote its ChloraPrep product to healthcare providers. That doctor, Charles Denham, received the kickbacks while serving as co-chair of the safe practices committee of the nonprofit National Quality Forum, which makes recommendations on healthcare practices, the Justice Department said. “Corrupting the standard-setting process through kickbacks can affect the healthcare treatment choices that doctors and hospitals may make for patients,” Stuart Delery, assistant attorney general for the Justice Department’s civil division, said in a statement. The lawsuit also claimed that CareFusion promoted ChloraPrep from September 2009 through August 2011 for unapproved uses. The U.S. Food and Drug Administration had approved ChloraPrep to prepare patients’ skin for surgery or injections. CareFusion said on Thursday that it set aside funds for the settlement in the first quarter of 2013. Chief Executive Officer Kieran Gallahue said the San Diego-based company is pleased to settle, and has made “significant investments” to improve its quality and compliance practices, including in sales and marketing. Denham could not immediately be reached for comment. The accord resolved a whistleblower lawsuit first brought in September 2010 by Cynthia Kirk, a former vice president of regulatory affairs at a CareFusion infection prevention unit. She will receive $3.26 million through the settlement, which along with the lawsuit was unsealed this week by the federal court in Kansas City, Kansas. In afternoon trading, CareFusion shares were up 81 cents at $41.12. The case is U.S. ex rel. Kirk v. CareFusion Corp et al, U.S. District Court, District of Kansas, No. 10-02492. Claim: CareFusion to pay $40 million to settle U.S. kickbacks lawsuit.


Output: CareFusion Corp agreed to pay $40.1 million to settle a federal government lawsuit accusing it of paying kickbacks to boost sales of a pre-surgical skin treatment, and marketing the product for unapproved uses.